SK281681B6 - Deriváty 2,3-dihydro-1,4-benzodioxín-5-yl-piperazínu, spôsob ich výroby a ich použitie - Google Patents

Deriváty 2,3-dihydro-1,4-benzodioxín-5-yl-piperazínu, spôsob ich výroby a ich použitie Download PDF

Info

Publication number
SK281681B6
SK281681B6 SK788-94A SK78894A SK281681B6 SK 281681 B6 SK281681 B6 SK 281681B6 SK 78894 A SK78894 A SK 78894A SK 281681 B6 SK281681 B6 SK 281681B6
Authority
SK
Slovakia
Prior art keywords
dihydro
benzodioxin
mmol
formula
chloro
Prior art date
Application number
SK788-94A
Other languages
English (en)
Slovak (sk)
Other versions
SK78894A3 (en
Inventor
Jan Hartog
Steen Bartholomeus Johannes Van
Johannes Mos
Jacques Schipper
Original Assignee
Duphar International Research B. V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar International Research B. V. filed Critical Duphar International Research B. V.
Publication of SK78894A3 publication Critical patent/SK78894A3/sk
Publication of SK281681B6 publication Critical patent/SK281681B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SK788-94A 1993-07-05 1994-06-30 Deriváty 2,3-dihydro-1,4-benzodioxín-5-yl-piperazínu, spôsob ich výroby a ich použitie SK281681B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93201950 1993-07-05

Publications (2)

Publication Number Publication Date
SK78894A3 SK78894A3 (en) 1995-03-08
SK281681B6 true SK281681B6 (sk) 2001-06-11

Family

ID=8213949

Family Applications (1)

Application Number Title Priority Date Filing Date
SK788-94A SK281681B6 (sk) 1993-07-05 1994-06-30 Deriváty 2,3-dihydro-1,4-benzodioxín-5-yl-piperazínu, spôsob ich výroby a ich použitie

Country Status (21)

Country Link
US (1) US5462942A (de)
EP (1) EP0633260B1 (de)
JP (1) JP3572102B2 (de)
KR (1) KR100363988B1 (de)
CN (1) CN1044244C (de)
AT (1) ATE208385T1 (de)
AU (1) AU680900B2 (de)
CA (1) CA2127084C (de)
CZ (1) CZ286503B6 (de)
DE (1) DE69428943T2 (de)
DK (1) DK0633260T3 (de)
ES (1) ES2167346T3 (de)
FI (1) FI120306B (de)
HU (1) HU218215B (de)
IL (1) IL110209A (de)
NO (1) NO301980B1 (de)
NZ (1) NZ260891A (de)
PT (1) PT633260E (de)
RU (1) RU2118322C1 (de)
SK (1) SK281681B6 (de)
ZA (1) ZA944787B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0812196A4 (de) * 1995-02-23 1998-05-20 Merck & Co Inc Alpha 1a adrenergische rezeptorantagonisten
US5952351A (en) * 1995-02-23 1999-09-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US6096763A (en) * 1995-02-23 2000-08-01 Merck & Co., Inc. α1a adrenergic receptor antagonists
US5620997A (en) * 1995-05-31 1997-04-15 Warner-Lambert Company Isothiazolones
AU7734496A (en) * 1995-11-15 1997-06-05 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
US6001863A (en) * 1996-11-26 1999-12-14 Warner-Lambert Company Isothiazolones
TW530054B (en) * 1997-09-24 2003-05-01 Duphar Int Res New piperazine and piperidine compounds
US6177566B1 (en) 1998-06-30 2001-01-23 Neurogen Corporation 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands
AR022303A1 (es) 1999-01-22 2002-09-04 Lundbeck & Co As H Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion
CN1081128C (zh) * 1999-08-18 2002-03-20 湖北省化学研究所 软性印刷电路板专用的高分子塑料薄膜双面复合金属板的制造方法
DE10031391A1 (de) * 2000-07-03 2002-02-07 Knoll Ag Bicyclische Verbindungen und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
JP5080716B2 (ja) 2001-07-20 2012-11-21 サイコジェニックス・インコーポレーテッド 注意欠陥・多動性障害の治療
KR20030084444A (ko) * 2002-04-26 2003-11-01 주식회사 파나진 Ｐｎａ 올리고머를 합성하기 위한 신규한 단량체 및 그의제조방법
US20040058962A1 (en) * 2002-06-14 2004-03-25 Amedeo Leonardi Phenylalkylamines and pyridylalkylamines
US7153849B2 (en) * 2002-09-12 2006-12-26 Wyeth Antidepressant arylpiperazine derivatives of hetrocycle-fused benzodioxans
US20040215284A1 (en) * 2003-01-30 2004-10-28 Recordati S.A. Treatment of neuromuscular dysfunction of the lower urinary tract with selective mGlu5 antagonists
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
US9066903B2 (en) 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease
CN111253335B (zh) * 2020-03-12 2023-06-06 浙江扬帆新材料股份有限公司 一种n-取代苯并异噻唑啉-3-酮衍生物的新合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2519986A1 (fr) * 1982-01-21 1983-07-22 Adir Nouveaux derives de benzodioxine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
US4656174A (en) * 1982-07-24 1987-04-07 Pfizer Inc. Quinoline therapeutic agents
JPS59118765A (ja) * 1982-12-24 1984-07-09 Fujisawa Pharmaceut Co Ltd ピペラジン誘導体
DK169601B1 (da) * 1983-10-17 1994-12-19 Duphar Int Res Piperazinderivater og farmaceutisk præparat indeholdende et sådant derivat, samt piperazinderivater med mellemproduktanvendelse
DE3571436D1 (en) * 1984-12-21 1989-08-17 Duphar Int Res New pharmaceutical compositions having anti-psychotic properties
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
DE3726425A1 (de) * 1987-03-18 1988-09-29 Bayer Ag Basisch substituierte saccharine
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
CA2004670A1 (en) * 1988-12-08 1990-06-08 Jan Hartog Anxiolytically active piperazine derivatives
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
JPH02184667A (ja) * 1989-01-11 1990-07-19 Meiji Seika Kaisha Ltd Ｎ，ｎ’―ジ置換ピペラジル誘導体及びそれを有効成分とする排尿障害改善剤
DE4127849A1 (de) * 1991-08-22 1993-02-25 Merck Patent Gmbh Benzodioxanderivate
GB9202915D0 (en) * 1992-02-12 1992-03-25 Wellcome Found Chemical compounds

Also Published As

Publication number Publication date
DE69428943D1 (de) 2001-12-13
SK78894A3 (en) 1995-03-08
NO942471L (no) 1995-01-06
CA2127084C (en) 2007-04-10
HUT75155A (en) 1997-04-28
RU94023250A (ru) 1996-08-10
IL110209A0 (en) 1994-10-21
NO942471D0 (no) 1994-06-30
RU2118322C1 (ru) 1998-08-27
DK0633260T3 (da) 2002-02-25
KR100363988B1 (ko) 2003-02-05
AU680900B2 (en) 1997-08-14
FI943149A (fi) 1995-01-06
DE69428943T2 (de) 2002-08-01
CA2127084A1 (en) 1995-01-06
NZ260891A (en) 1995-04-27
IL110209A (en) 2000-02-29
EP0633260B1 (de) 2001-11-07
PT633260E (pt) 2002-04-29
ES2167346T3 (es) 2002-05-16
CN1106813A (zh) 1995-08-16
HU218215B (hu) 2000-06-28
JP3572102B2 (ja) 2004-09-29
FI120306B (fi) 2009-09-15
CZ159794A3 (en) 1995-05-17
KR950003289A (ko) 1995-02-16
ZA944787B (en) 1995-02-20
CZ286503B6 (en) 2000-04-12
EP0633260A1 (de) 1995-01-11
JPH07215972A (ja) 1995-08-15
AU6613994A (en) 1995-01-12
NO301980B1 (no) 1998-01-05
US5462942A (en) 1995-10-31
FI943149A0 (fi) 1994-06-30
HU9401965D0 (en) 1994-09-28
ATE208385T1 (de) 2001-11-15
CN1044244C (zh) 1999-07-21

Similar Documents

Publication Publication Date Title
EP0633260B1 (de) 2,3-Dihydro-1,4-Benzodioxan-5-yl-piperazinderivate als 5-HT1A-Antagonisten
EP1708713B1 (de) 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-chinazolin-2-on-derivate und die jeweiligen 1h-benzo(1,2,6)thiadiazin-2,2-dioxid und 1,4-dihydro-benzo(d)(1,3)oxazin-2-on-derivate als modulatoren des 5-hydroxytryptamin-rezeptors (5-ht) zur behandlung von erkrankungen des zentralen nervensystems
US4704390A (en) Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents
CA2535385A1 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
FR2655988A1 (fr) Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US6391891B1 (en) Bicyclic compounds as ligands for 5-HT1 receptors
NO860319L (no) Fremgangsmaate for fremstillig av terapeutisk aktive 4h-1-benzopyran-4-on-derivater og deres svovelholdige analoger.
CA2575785A1 (en) 5-ht7 receptor antagonists
EP0650964A1 (de) 1- 2H-1-Benzopyran-2-on-8-yl -Piperazin Derivate
JPH05194441A (ja) 新規な置換３−ピペラジニルアルキル−２，３−ジヒドロ−４ｈ−１，３−ベンゾオキサジン−４−オン、その製造法および治療用途
AU726681B2 (en) New heterocyclic aminomethyl compounds, process for preparing them and pharmaceutical compositions containing them
FI85484C (fi) Foerfarande foer framstaellning av antipsykotiska pyridinylpiperazinderivat som innehaoller en kondenserad ring.
CA2320116C (en) 2-aminoquinoline derivatives having d4-agonistic activity
RU1838309C (ru) Способ получени производных хиназолина или их формацевтически приемлемых кислотно-аддитивных солей
PL105558B1 (pl) Sposob wytwarzania 2-/4-podstawionych piperazynylo-1/-4-aminochinazolin
SK62002A3 (en) Benzofurane derivative, process for the preparation thereof and pharmaceutical composition comprising same
CA2414115A1 (en) Indole derivatives useful for the treatment of cns disorders
SK8652003A3 (en) Piperazinylcarbonylquinoline and piperazinylcarbonylisoquinoline derivative, process for the preparation thereof, use and pharmaceutical composition comprising same
CA2414726A1 (en) Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia
US6166205A (en) 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands
JP2009514828A (ja) ５−ｈｔ６阻害剤としてのアリールスルホニルクロマン類、タンパク質キナーゼ阻害剤としてのインドリルマレイミド誘導体
JPS6064976A (ja) Ν−置換フラボン−８−カルボキサミド誘導体，及びその製造方法
Berger et al. Arylsulfonyl chromans as 5-HT 6 inhibitors
CA2278718A1 (en) 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-thiones derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20110630